Back to Screener

Healthcare

MediPal Holdings Corporation(MEPDF)

Live Price

Offline

$18.35

+0.00% today

1Y Change

+12.92%

Window

Jun 25, 2025 โ†’ Jun 23, 2026

Market Cap
$576.23B
Revenue Growth
+3.2%
EPS Growth
-1.3%
Dividend Yield
2.3%

Coverage: 256 bars ยท Jun 25, 2025 โ†’ Jun 23, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

MediPal Holdings Corporation (MEPDF) is a Healthcare stock with a market cap of $576.23B and listed on OTC. The stock last traded around $18.35 and up 12.9% across the available one-year price window (Jun 25, 2025 โ†’ Jun 23, 2026). Baseline metrics include revenue growth of +3.2%, EPS growth of -1.3%, a dividend yield of 2.3%. What stands out right now is revenue +3.2%, EPS -1.3%, free cash flow +13.4% with operating margin 1.4% and ROIC 4.3%. The dividend is present but secondary, with a yield around 2.3%. Valuation is more restrained than many high-expectation growth names at P/E 13.9 and price/sales 0.2. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines MEPDF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

MEPDF vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

MEPDF

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

MEPDF Max Drawdown

-3.42%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for MEPDF and SPY.

Calendar-year return history is still loading or unavailable.

Unable to load analyst forecasts.

Timed out loading forecasts for MEPDF

Next Step

Put consensus data in context

Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.